D. Hawellek, D. Engemann, Š. Holiga, A. Napolitano, M. Abaei, P. McColgan
{"title":"E10基于tominersen III期试验一代亨廷顿舞蹈病(HD)的脑年龄作为基于成像的疾病病理学标志物的临床应用的横断面探索","authors":"D. Hawellek, D. Engemann, Š. Holiga, A. Napolitano, M. Abaei, P. McColgan","doi":"10.1136/jnnp-2022-ehdn.86","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":205061,"journal":{"name":"E: Imaging","volume":"154 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington’s disease (HD) based on the tominersen phase III trial generation HD 1\",\"authors\":\"D. Hawellek, D. Engemann, Š. Holiga, A. Napolitano, M. Abaei, P. McColgan\",\"doi\":\"10.1136/jnnp-2022-ehdn.86\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":205061,\"journal\":{\"name\":\"E: Imaging\",\"volume\":\"154 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"E: Imaging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jnnp-2022-ehdn.86\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"E: Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2022-ehdn.86","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington’s disease (HD) based on the tominersen phase III trial generation HD 1